{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T08:15:42Z","timestamp":1794730542002,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Natural Science Research Projects in Anhui Universities"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Many studies have shown that long-noncoding RNA (lncRNA) is associated with cardiovascular disease, but its molecular mechanism is still unclear. In this study, we explored the role of lncRNA ANRIL in ox-LDL-induced phenotypic transition of human aortic smooth muscle cells (HASMC). The results of quantitative fluorescence PCR showed that the expression of ANRIL in patients with coronary atherosclerotic heart disease (CAD) was significantly higher than that in normal subjects. RNA-FISH detection showed that the ANRIL expression increased in HASMC treated by ox-LDL. Ox-LDL could upregulate the expression of ANRIL and ROS and promote the phenotypic transition of HASMC. After downregulation of ANRIL by siRNA, ROS level decreased and HASMC phenotypic transition alleviated. ANRIL could act as a molecular scaffold to promote the binding of WDR5 and HDAC3 to form WDR5 and HDAC3 complexes, they regulated target genes such as NOX1 expression by histone modification, upregulated ROS level and promote HASMC phenotype transition. Therefore, we found a new epigenetic regulatory mechanism for phenotype transition of VSMC, ANRIL was a treatment target of occlusive vascular diseases.<\/jats:p>","DOI":"10.1038\/s41419-020-2645-3","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T10:05:56Z","timestamp":1591610756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["LncRNA ANRIL acts as a modular scaffold of WDR5 and HDAC3 complexes and promotes alteration of the vascular smooth muscle cell phenotype"],"prefix":"10.1038","volume":"11","author":[{"given":"Chengxin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangqing","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"2645_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2174\/1573403X14666180820151325","volume":"14","author":"P Ohukainen","year":"2018","unstructured":"Ohukainen, P., Ruskoaho, H. & Rysa, J. Cellular mechanisms of valvular thickening in early and intermediate calcific aortic valve disease. Curr. Cardiol. Rev. 14, 264\u2013271 (2018).","journal-title":"Curr. Cardiol. Rev."},{"key":"2645_CR2","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1253\/circj.CJ-17-1029","volume":"81","author":"K Satoh","year":"2017","unstructured":"Satoh, K. Development of novel therapies for cardiovascular diseases by clinical application of basic research. Circ. J. 81, 1557\u20131563 (2017).","journal-title":"Circ. J."},{"key":"2645_CR3","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1161\/ATVBAHA.118.311727","volume":"39","author":"M Clement","year":"2019","unstructured":"Clement, M. et al. Vascular smooth muscle cell plasticity and autophagy in dissecting aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 39, 1149\u20131159 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2645_CR4","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13934","volume":"7","author":"AJA Leloup","year":"2019","unstructured":"Leloup, A. J. A. et al. Vascular smooth muscle cell contraction and relaxation in the isolated aorta: a critical regulator of large artery compliance. Physiol. Rep. 7, e13934 (2019).","journal-title":"Physiol. Rep."},{"key":"2645_CR5","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1159\/000443123","volume":"38","author":"DA Chistiakov","year":"2016","unstructured":"Chistiakov, D. A., Orekhov, A. N. & Bobryshev, Y. V. LOX-1-mediated effects on vascular cells in atherosclerosis. Cell Physiol. Biochem. 38, 1851\u20131859 (2016).","journal-title":"Cell Physiol. Biochem."},{"key":"2645_CR6","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.bbadis.2018.09.033","volume":"1865","author":"H Zhu","year":"2019","unstructured":"Zhu, H. et al. Aldehyde dehydrogenase 2 deficiency promotes atherosclerotic plaque instability through accelerating mitochondrial ROS-mediated vascular smooth muscle cell senescence. Biochim. Biophys. Acta Mol. Basis. Dis. 1865, 1782\u20131792 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis. Dis."},{"key":"2645_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/apha.12466","volume":"214","author":"DA Chistiakov","year":"2015","unstructured":"Chistiakov, D. A., Orekhov, A. N. & Bobryshev, Y. V. Vascular smooth muscle cell in atherosclerosis. Acta Physiol. 214, 33\u201350 (2015).","journal-title":"Acta Physiol."},{"key":"2645_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000441621","volume":"52","author":"VA Belo","year":"2015","unstructured":"Belo, V. A., Guimaraes, D. A. & Castro, M. M. Matrix metalloproteinase 2 as a potential mediator of vascular smooth muscle cell migration and chronic vascular remodeling in hypertension. J. Vasc. Res. 52, 221\u2013231 (2015).","journal-title":"J. Vasc. Res."},{"key":"2645_CR9","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1111\/jcmm.13269","volume":"21","author":"TM Wang","year":"2017","unstructured":"Wang, T. M. et al. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype. J. Cell Mol. Med. 21, 3592\u20133601 (2017).","journal-title":"J. Cell Mol. Med."},{"key":"2645_CR10","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1161\/ATVBAHA.116.307879","volume":"36","author":"J Zhao","year":"2016","unstructured":"Zhao, J. et al. MYOSLID is a novel serum response factor-dependent long noncoding rna that amplifies the vascular smooth muscle differentiation program. Arterioscler. Thromb. Vasc. Biol. 36, 2088\u20132099 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2645_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-981-13-1426-1_23","volume":"1087","author":"S Ding","year":"2018","unstructured":"Ding, S. et al. Circular RNAs in vascular functions and diseases. Adv. Exp. Med. Biol. 1087, 287\u2013297 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2645_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.yjmcc.2014.12.014","volume":"89","author":"C Beltrami","year":"2015","unstructured":"Beltrami, C., Angelini, T. G. & Emanueli, C. Noncoding RNAs in diabetes vascular complications. J. Mol. Cell. Cardiol. 89, 42\u201350 (2015).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2645_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yjmcc.2015.02.002","volume":"89","author":"MT Piccoli","year":"2015","unstructured":"Piccoli, M. T., Gupta, S. K. & Thum, T. Noncoding RNAs as regulators of cardiomyocyte proliferation and death. J. Mol. Cell. Cardiol. 89, 59\u201367 (2015).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2645_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fonc.2018.00502","volume":"8","author":"K Lu","year":"2018","unstructured":"Lu, K., Tao, H., Si, X. & Chen, Q. The histone H3 lysine 4 presenter WDR5 as an oncogenic protein and novel epigenetic target in cancer. Front. Oncol. 8, 502 (2018).","journal-title":"Front. Oncol."},{"key":"2645_CR15","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1158\/2159-8290.CD-15-0921","volume":"6","author":"TT Sun","year":"2016","unstructured":"Sun, T. T. et al. LncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern. Cancer Discov. 6, 784\u2013801 (2016).","journal-title":"Cancer Discov."},{"key":"2645_CR16","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1158\/0008-5472.CAN-15-0423","volume":"75","author":"Y Sun","year":"2015","unstructured":"Sun, Y. et al. WDR5 supports an N-Myc transcriptional complex that drives a protumorigenic gene expression signature in neuroblastoma. Cancer Res. 75, 5143\u20135154 (2015).","journal-title":"Cancer Res."},{"key":"2645_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.molcel.2011.07.012","volume":"43","author":"MZ Wu","year":"2011","unstructured":"Wu, M. Z. et al. Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition. Mol. Cell 43, 811\u2013822 (2011).","journal-title":"Mol. Cell"},{"key":"2645_CR18","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1136\/gut.2005.078865","volume":"55","author":"N Uyama","year":"2006","unstructured":"Uyama, N. et al. Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions. Gut 55, 1276\u20131289 (2006).","journal-title":"Gut"},{"key":"2645_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08131-6","volume":"7","author":"Y Huang","year":"2017","unstructured":"Huang, Y. et al. Knockdown of lncRNA MIR31HG inhibits adipocyte differentiation of human adipose-derived stem cells via histone modification of FABP4. Sci. Rep. 7, 8080 (2017).","journal-title":"Sci. Rep."},{"key":"2645_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0879-9","volume":"17","author":"LY Sun","year":"2018","unstructured":"Sun, L. Y. et al. LncRNA ANRIL regulates AML development through modulating the glucose metabolism pathway of AdipoR1\/AMPK\/SIRT1. Mol. Cancer 17, 127 (2018).","journal-title":"Mol. Cancer"},{"key":"2645_CR21","doi-asserted-by":"publisher","first-page":"17347","DOI":"10.18632\/oncotarget.14468","volume":"8","author":"B Zhang","year":"2017","unstructured":"Zhang, B., Wang, D., Ji, T. F., Shi, L. & Yu, J. L. Overexpression of lncRNA ANRIL up-regulates VEGF expression and promotes angiogenesis of diabetes mellitus combined with cerebral infarction by activating NF-kappaB signaling pathway in a rat model. Oncotarget 8, 17347\u201317359 (2017).","journal-title":"Oncotarget"},{"key":"2645_CR22","first-page":"82","volume":"43","author":"J Yu","year":"2015","unstructured":"Yu, J., Wu, G. & Zeng, C. Update on the role of LncRNA ANRIL at human chromosome 9p21 on the pathogenesis of atherosclerosis. Zhonghua. Xin. Xue. Guan. Bing. Za. Zhi 43, 82\u201385 (2015).","journal-title":"Zhonghua. Xin. Xue. Guan. Bing. Za. Zhi"},{"key":"2645_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12429","volume":"7","author":"LM Holdt","year":"2016","unstructured":"Holdt, L. M. et al. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat. Commun. 7, 12429 (2016).","journal-title":"Nat. Commun."},{"key":"2645_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/cvr\/cvs115","volume":"95","author":"D Gomez","year":"2012","unstructured":"Gomez, D. & Owens, G. K. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc. Res. 95, 156\u2013164 (2012).","journal-title":"Cardiovasc. Res."},{"key":"2645_CR25","doi-asserted-by":"publisher","first-page":"E21","DOI":"10.3390\/jcm7020021","volume":"7","author":"AD Guarnaccia","year":"2018","unstructured":"Guarnaccia, A. D. & Tansey, W. P. Moonlighting with WDR5: a cellular multitasker. J. Clin. Med. 7, E21 (2018).","journal-title":"J. Clin. Med."},{"key":"2645_CR26","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.redox.2014.04.004","volume":"2","author":"S Xu","year":"2014","unstructured":"Xu, S., Chamseddine, A. H., Carrell, S. & Miller, F. J. Jr. Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques. Redox Biol. 2, 642\u2013650 (2014).","journal-title":"Redox Biol."},{"key":"2645_CR27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/ATVBAHA.114.304936","volume":"35","author":"AI Rodriguez","year":"2015","unstructured":"Rodriguez, A. I. et al. MEF2B-Nox1 signaling is critical for stretch-induced phenotypic modulation of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 35, 430\u2013438 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2645_CR28","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.celrep.2015.10.013","volume":"13","author":"CB Greer","year":"2015","unstructured":"Greer, C. B. et al. Histone deacetylases positively regulate transcription through the elongation machinery. Cell. Rep. 13, 1444\u20131455 (2015).","journal-title":"Cell. Rep."},{"key":"2645_CR29","first-page":"816","volume":"37","author":"JS Chi","year":"2017","unstructured":"Chi, J. S. et al. Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis. J. Huazhong. Univ. Sci. Technol. Med. Sci. 37, 816\u2013822 (2017).","journal-title":"J. Huazhong. Univ. Sci. Technol. Med. Sci."},{"key":"2645_CR30","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1159\/000478918","volume":"42","author":"CL Song","year":"2017","unstructured":"Song, C. L. et al. Effect of circular ANRIL on the inflammatory response of vascular endothelial cells in a rat model of coronary atherosclerosis. Cell Physiol. Biochem. 42, 1202\u20131212 (2017).","journal-title":"Cell Physiol. Biochem."},{"key":"2645_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/ATVBAHA.109.196832","volume":"30","author":"LM Holdt","year":"2010","unstructured":"Holdt, L. M. et al. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler. Thromb. Vasc. Biol. 30, 620\u2013627 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2645_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fcvm.2018.00145","volume":"5","author":"LM Holdt","year":"2018","unstructured":"Holdt, L. M., Teupser, D. & Long Noncoding, R. N. A. ANRIL: Lnc-ing genetic variation at the chromosome 9p21 locus to molecular mechanisms of atherosclerosis. Front. Cardiovasc. Med. 5, 145 (2018).","journal-title":"Front. Cardiovasc. Med."},{"key":"2645_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4831-6","volume":"18","author":"D Huang","year":"2018","unstructured":"Huang, D. et al. Knockdown long non-coding RNA ANRIL inhibits proliferation, migration and invasion of HepG2 cells by down-regulation of miR-191. BMC Cancer 18, 919 (2018).","journal-title":"BMC Cancer"},{"key":"2645_CR34","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1002\/jcb.26437","volume":"119","author":"X Dong","year":"2018","unstructured":"Dong, X. et al. Knockdown of long non-coding RNA ANRIL inhibits proliferation, migration, and invasion but promotes apoptosis of human glioma cells by upregulation of miR-34a. J. Cell Biochem. 119, 2708\u20132718 (2018).","journal-title":"J. Cell Biochem."},{"key":"2645_CR35","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3892\/mmr.2016.5409","volume":"14","author":"Y Sun","year":"2016","unstructured":"Sun, Y., Zheng, Z. P., Li, H., Zhang, H. Q. & Ma, F. Q. ANRIL is associated with the survival rate of patients with colorectal cancer, and affects cell migration and invasion in vitro. Mol. Med. Rep. 14, 1714\u20131720 (2016).","journal-title":"Mol. Med. Rep."},{"key":"2645_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.yexmp.2019.01.011","volume":"107","author":"F Chen","year":"2019","unstructured":"Chen, F., Li, M. & Zhu, X. Propofol suppresses proliferation and migration of papillary thyroid cancer cells by down-regulation of lncRNA ANRIL. Exp. Mol. Pathol. 107, 68\u201376 (2019).","journal-title":"Exp. Mol. Pathol."},{"key":"2645_CR37","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.4103\/1673-5374.189159","volume":"11","author":"DT Hass","year":"2016","unstructured":"Hass, D. T. & Barnstable, C. J. Uncoupling protein 2 in the glial response to stress: implications for neuroprotection. Neural Regen. Res. 11, 1197\u20131200 (2016).","journal-title":"Neural Regen. Res."},{"key":"2645_CR38","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/ATVBAHA.117.309228","volume":"37","author":"WN Nowak","year":"2017","unstructured":"Nowak, W. N., Deng, J., Ruan, X. Z. & Xu, Q. Reactive oxygen species generation and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 37, e41\u2013e52 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2645_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev.pharmtox.39.1.243","volume":"39","author":"KS Ramos","year":"1999","unstructured":"Ramos, K. S. Redox regulation of c-Ha-ras and osteopontin signaling in vascular smooth muscle cells: implications in chemical atherogenesis. Annu. Rev. Pharmacol. Toxicol. 39, 243\u2013265 (1999).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2645_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.coph.2019.04.012","volume":"45","author":"HJ Man","year":"2019","unstructured":"Man, H. J. & Marsden, P. A. LncRNAs and epigenetic regulation of vascular endothelium: genome positioning system and regulators of chromatin modifiers. Curr. Opin. Pharmacol. 45, 72\u201380 (2019).","journal-title":"Curr. Opin. Pharmacol."},{"key":"2645_CR41","doi-asserted-by":"publisher","first-page":"20170074","DOI":"10.1098\/rstb.2017.0074","volume":"373","author":"DJ Hanly","year":"2018","unstructured":"Hanly, D. J., Esteller, M. & Berdasco, M. Interplay between long non-coding RNAs and epigenetic machinery: emerging targets in cancer? Philos. Trans. R. Soc. Lond. B. Biol. Sci. 373, 20170074 (2018).","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"2645_CR42","first-page":"3912","volume":"61","author":"C Chu","year":"2012","unstructured":"Chu, C., Quinn, J. & Chang, H. Y. Chromatin isolation by RNA purification (ChIRP). J. Vis. Exp. 61, 3912 (2012).","journal-title":"J. Vis. Exp."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2645-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2645-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2645-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:00:56Z","timestamp":1670252456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2645-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["2645"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2645-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"18 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"435"}}